Fenfluramine Hydrochloride

Fenfluramine in CDKL5 Deficiency Disorder (CDD)

Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE, MULTICENTER STUDY TO EXAMINE THE EFFICACY AND SAFETY OF ZX008 IN SUBJECTS WITH CDKL5 DEFICIENCY DISORDER FOLLOWED BY AN OPEN-LABEL EXTENSION

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

ZX008 Expanded Access Protocol

Using Fenfluramine to Test the Serotonin Deficiency Theory of Depression